STOCK TITAN

SI-BONE, Inc. (SIBN) director sells 20,000 shares after option exercise

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SI-BONE director Jeffrey W. Dunn exercised stock options for 20,000 shares of common stock at $4.68 per share and on the same date sold 20,000 shares at a weighted-average price of $18.4607 pursuant to a Rule 10b5-1 plan dated May 7, 2025. Following these trades he holds 106,260 shares directly, including 10,957 underlying restricted stock units, plus 81,073 shares held indirectly through a living trust.

Positive

  • None.

Negative

  • None.
Insider DUNN JEFFREY W
Role Director
Sold 20,000 shs ($369K)
Approx. gross sale proceeds $369K
Approx. exercise cost $94K
Approx. pre-tax spread $276K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F5 20,000 $0.00 $0.00
Exercise Common Stock 20,000 $4.68 $94K
Sale Common Stock F1, F2, F3 20,000 $18.4607 $369K
holding Common Stock F4 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 106,260 shares (Direct); Common Stock — 16,057 shares (Direct); Common Stock — 81,073 shares (Indirect, by Trust)
Footnotes (5)
  1. F1. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025.
  2. F2. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.20 to $18.93, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  4. F4. Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.
  5. F5. The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
Options Exercised 20,000 shares Stock options for common stock exercised on 2026-08-03 at $4.6800 per share
Shares Sold 20,000 shares Common stock sold on 2026-08-03 at a weighted-average price of $18.4607 per share
Sale Price Range $18.20 to $18.93 per share Multiple sale transactions within this price range as disclosed in a footnote
Direct Holdings After Exercise 106,260 shares Common stock beneficially owned directly by Jeffrey W. Dunn after the reported transactions
Indirect Trust Holdings 81,073 shares Common stock held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012
Restricted Stock Units 10,957 shares Shares issuable upon settlement of restricted stock units included in direct holdings
Rule 10b5-1 trading plan regulatory
"The sale was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"Includes 10,957 shares issuable on the settlement of restricted stock units granted."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted-average price financial
"The price reported in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
Stock Option (Right to Buy) financial
"Derivative security titled Stock Option (Right to Buy) for 20,000 shares."
Living Trust financial
"Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider stock transactions did SI-BONE (SIBN) director Jeffrey W. Dunn report?

Jeffrey W. Dunn exercised 20,000 stock options at $4.68 per share and sold 20,000 common shares at a weighted-average price of $18.4607 on August 3, 2026. The sale was executed under a pre-arranged Rule 10b5-1 trading plan dated May 7, 2025.

How many SI-BONE (SIBN) shares did Jeffrey W. Dunn sell and at what price?

He sold 20,000 SI-BONE common shares at a weighted-average price of $18.4607 per share. Footnotes state the sales occurred in multiple trades within a price range of $18.20 to $18.93 per share on August 3, 2026.

Was Jeffrey W. Dunn’s SI-BONE (SIBN) share sale made under a Rule 10b5-1 plan?

Yes. The reported sale of 20,000 SI-BONE shares was effected pursuant to a Rule 10b5-1 trading plan dated May 7, 2025. Such plans pre-schedule trades, which can reduce the informational value of transaction timing for outside investors.

What SI-BONE (SIBN) shares does Jeffrey W. Dunn hold after these transactions?

After the transactions, Dunn holds 106,260 common shares directly, including 10,957 shares issuable upon settlement of restricted stock units, and 81,073 shares indirectly through The Jeffrey W. Dunn Living Trust dated May 17, 2012.

What stock options did Jeffrey W. Dunn exercise in SI-BONE (SIBN)?

He exercised options for 20,000 shares of common stock at an exercise price of $4.6800 per share. Footnotes explain these option shares vest in equal monthly installments over four years, subject to his continued service, and expire on March 1, 2027.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DUNN JEFFREY W

(Last)(First)(Middle)
C/O SI-BONE, INC.
471 EL CAMINO REAL, SUITE 101

(Street)
SANTA CLARA CALIFORNIA 95050

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SI-BONE, Inc. [ SIBN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/03/2026M20,000A$4.6836,057D
Common Stock08/03/2026S(1)20,000D$18.4607(2)16,057(3)D
Common Stock81,073Iby Trust(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$4.6808/03/2026M20,000 (5)03/01/2027Common Stock20,000$0.00106,260D
Explanation of Responses:
1. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025.
2. The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.20 to $18.93, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
4. Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.
5. The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.
Remarks:
/s/ Michael A. Pisetsky, Attorney-in-Fact for Jeffrey W. Dunn08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)